image
Neurocrine Biosciences, Inc. NBIX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 118.7325
1.04 %
$ 11.8 B
Market Cap
36.09
P/E
CASH FLOW STATEMENT
595 M OPERATING CASH FLOW
52.71%
Growth Rates
1Year 52.71%
3Years 32.41%
5Years 31.39%
7Years 35.33%
10Years 30.78%
-127 M INVESTING CASH FLOW
72.85%
Growth Rates
1Year 72.85%
3Years 0.88%
5Years 9.69%
7Years 9.29%
10Years -1.87%
-487 M FINANCING CASH FLOW
-745.33%
Growth Rates
1Year -745.33%
3Years -165.72%
5Years -79.85%
7Years -9.95%
10Years -16.25%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Neurocrine Biosciences, Inc.
image
Net Income 341 M
Depreciation & Amortization -2.7 M
Capital Expenditures -38.2 M
Stock-Based Compensation 196 M
Change in Working Capital 0
Others 184 M
Free Cash Flow 557 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
OPERATING CASH FLOW
Net Income 341.3 249.7 154.5 89.6 407.3 37.0 21.1 (142.5) (141.1) (88.9) (60.5) (46.1) 5.0 37.6 (8.0) (51.0) (88.6) (207.3) (107.2) (22.2) (45.8) (30.3) (94.5) (36.9) (28.8) (16.8) (20.0) 5.1 5.9
Depreciation & Amortization (2.7) 21.3 15.6 10.9 8.6 7.5 4.0 2.4 1.5 1.0 0.8 0.7 0.7 0.7 1.4 3.2 7.6 9.4 10.6 10.1 7.1 3.7 3.1 2.7 2.2 2.1 1.7 1.3 1.0
Deferred Income Tax (123.1) (56.7) 19.1 4.3 (310.7) 11.0 0.7 (0.3) 89 K 2.7 0.6 (0.3) 61 K (0.8) (3.5) 4.8 4.2 (10.1) (13.9) (0.5) (0.5) 44.9 (1.2) 0 0 0 0 0 0
Stock Based Compensation 195.5 194.3 173.1 134.2 100.0 75.3 58.1 42.5 28.5 28.4 10.4 6.8 5.5 2.9 3.1 5.5 8.0 10.0 14.4 0.5 0.5 1.7 1.2 0 0 0 0 0 0
Other Operating Activities 184.4 (46.9) 44.5 0.8 61.2 21.1 19.2 12.4 (0.9) 10.1 14 K (2.8) (32.8) (36.5) 66.0 (2.4) 6.7 121.8 7.9 (22.0) (36.4) 81 K (1.4) 10.6 7.5 2.2 9.9 2.8 0.5
Change in Working Capital 0 28.2 (67.4) 16.7 (37.9) 0.2 (1.8) (8.8) 5.8 8.7 1.6 12.1 (13.7) (4.5) (9.2) (13.2) (12.1) 16.9 (11.0) 3.3 (24.9) 17.0 13.5 1.8 0.4 2.2 (2.3) 1.8 (0.7)
Cash From Operations 595.4 389.9 339.4 256.5 228.5 152.1 101.4 (94.3) (106.2) (38.0) (47.1) (29.6) (35.3) (0.7) 49.9 (53.1) (74.2) (59.3) (99.3) (30.8) (100.0) 37.1 (79.4) (21.9) (18.6) (10.3) (10.7) 11.0 6.7
INVESTING CASH FLOW
Capital Expenditures (38.2) (28.3) (16.5) (23.4) (10.9) (14.7) (24.8) (6.9) (4.1) (1.9) (1.6) (0.5) (1.0) (0.8) (0.3) 35 K (1.3) (0.6) (3.1) (7.2) (53.1) (50.4) (5.3) (3.8) (2.4) (2.1) (3.8) (6.4) (1.6)
Other Items (88.6) (438.8) (160.6) (106.8) 15.0 (196.3) (218.1) (243.9) 117.0 (193.9) (103.8) 5.9 (33.8) (2.8) (54.4) 12.1 45.8 21.5 123.4 16.6 71.6 (136.2) (40.7) (12.8) (73.2) (19.1) 8.5 (0.8) (47.0)
Cash From Investing Activities (126.8) (467.1) (177.1) (130.2) 4.1 (211.1) (242.9) (250.9) 112.9 (195.8) (105.4) 5.3 (34.8) (3.5) (54.7) 12.1 44.4 20.8 120.3 9.4 18.5 (186.6) (46.0) (16.6) (75.7) (21.2) 4.7 (7.2) (48.6)
FINANCING CASH FLOW
Common Stock Repurchased (300.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid (308.8) 0 (279.0) 100 K (186.9) 0 0 502.8 0 0 0 0 0 0 0 0 (1.5) 56.6 (5.8) (6.6) 29.7 14.4 2.2 1.8 0.8 0 1.5 100 K (0.7)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 122.1 65.3 0 27.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 15 K 0 0 100 K 0
Cash From Financing Activities (486.7) 65.3 (234.3) 27.4 (157.8) 27.3 29.5 516.6 2.4 277.0 138.7 5.3 83.7 0.3 21.5 9.9 (1.5) 57.2 10.1 10.3 36.7 211.1 5.8 181.3 94.1 41.0 1.9 0.7 46.8
CHANGE IN CASH
Net Change In Cash (18.1) (11.6) (73.3) 153.7 74.8 (31.7) (112.0) 171.4 9.1 43.2 (13.8) (19.0) 13.6 (3.9) 16.7 (31.1) (31.2) 18.7 31.0 (11.1) (44.8) 61.5 (119.6) 142.8 (0.2) 9.6 (4.1) 4.5 4.9
FREE CASH FLOW
Free Cash Flow 557.2 361.6 322.9 233.1 217.6 137.3 76.6 (101.3) (110.3) (39.9) (48.8) (30.2) (36.3) (1.4) 49.6 (53.1) (75.5) (60.0) (102.4) (38.0) (153.1) (13.3) (84.7) (25.7) (21.1) (12.4) (14.5) 4.6 5.1